120 related articles for article (PubMed ID: 29763415)
21. Identification of patients with high-risk stage II colon cancer for adjuvant therapy.
Quah HM; Chou JF; Gonen M; Shia J; Schrag D; Landmann RG; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR
Dis Colon Rectum; 2008 May; 51(5):503-7. PubMed ID: 18322753
[TBL] [Abstract][Full Text] [Related]
22. Prognostic factors for patients with stage II colon cancer: results of a prospective study.
Zhang C; Di J; Jiang B; Cui M; Wang Z; Xing J; Yang H; Yao Z; Zhang N; Su X
Int J Colorectal Dis; 2016 Jan; 31(1):123-9. PubMed ID: 26474869
[TBL] [Abstract][Full Text] [Related]
23. Memory defect induced by β-amyloid plus glutamate receptor agonist is alleviated by catalpol and donepezil through different mechanisms.
Xia Z; Zhang R; Wu P; Xia Z; Hu Y
Brain Res; 2012 Mar; 1441():27-37. PubMed ID: 22305339
[TBL] [Abstract][Full Text] [Related]
24. Factors predicting oncologic outcomes in patients with fewer than 12 lymph nodes retrieved after curative resection for colon cancer.
Huh JW; Kim CH; Kim HR; Kim YJ
J Surg Oncol; 2012 Feb; 105(2):125-9. PubMed ID: 21837680
[TBL] [Abstract][Full Text] [Related]
25. Contiguous invasion per se does not affect prognosis in colon cancer.
Oh SY; Kim YB; Paek OJ; Suh KW
J Surg Oncol; 2009 Jan; 99(1):71-4. PubMed ID: 18937290
[TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness analysis of oxaliplatin compared with 5-fluorouracil/leucovorin in adjuvant treatment of stage III colon cancer in the US.
Aballéa S; Chancellor JV; Raikou M; Drummond MF; Weinstein MC; Jourdan S; Bridgewater J
Cancer; 2007 Mar; 109(6):1082-9. PubMed ID: 17265519
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic approach in locally advanced colon tumours (T4NxM0) - clinical experience in 18 consecutive cases.
Marincaş M; Cirimbei C; Prunoiu V; Lucenco L; Buzatu R; Ionescu S; Mihaila D; Stefan I; Brătucu E
Chirurgia (Bucur); 2014; 109(1):20-5. PubMed ID: 24524466
[TBL] [Abstract][Full Text] [Related]
28. Relationship between [corrected] spatial memory in diabetic rats and protein kinase Cγ, caveolin-1 in the hippocampus and neuroprotective effect of catalpol.
Zhou H; Liu J; Ren L; Liu W; Xing Q; Men L; Song G; Du J
Chin Med J (Engl); 2014; 127(5):916-23. PubMed ID: 24571888
[TBL] [Abstract][Full Text] [Related]
29. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
30. The efficacy of oral tegafur-uracil as maintenance therapy following intravenous 5-fluorouracil chemotherapy in stage III colon cancer.
Hong KD; Lee SI; Moon HY
Hepatogastroenterology; 2012; 59(113):104-7. PubMed ID: 22251527
[TBL] [Abstract][Full Text] [Related]
31. Stage III Colon Cancer: The Individualized Strategy of Adjuvant Chemotherapy for Aged Under and Over 70.
Lu CS; Chang PY; Chen YG; Chen JH; Wu YY; Ho CL
PLoS One; 2015; 10(9):e0138632. PubMed ID: 26382962
[TBL] [Abstract][Full Text] [Related]
32. Lymphovascular invasion: a comprehensive appraisal in colon and rectal adenocarcinoma.
Hogan J; Chang KH; Duff G; Samaha G; Kelly N; Burton M; Burton E; Coffey JC
Dis Colon Rectum; 2015 Jun; 58(6):547-55. PubMed ID: 25944426
[TBL] [Abstract][Full Text] [Related]
33. Long-term outcomes after resection of para-aortic lymph node metastasis from left-sided colon and rectal cancer.
Nakai N; Yamaguchi T; Kinugasa Y; Shiomi A; Kagawa H; Yamakawa Y; Numata M; Furutani A
Int J Colorectal Dis; 2017 Jul; 32(7):999-1007. PubMed ID: 28382511
[TBL] [Abstract][Full Text] [Related]
34. Plasma glucose lowering mechanisms of catalpol, an active principle from roots of Rehmannia glutinosa, in streptozotocin-induced diabetic rats.
Shieh JP; Cheng KC; Chung HH; Kerh YF; Yeh CH; Cheng JT
J Agric Food Chem; 2011 Apr; 59(8):3747-53. PubMed ID: 21391677
[TBL] [Abstract][Full Text] [Related]
35. [Radical surgery for locally advanced recurrent sigmoid colon cancer].
Zavaruev AV; Mazurenko AA; Bregadze EY; Shumsky SV; Achkasov IA; Simonenko AA
Khirurgiia (Mosk); 2018; (5):108-109. PubMed ID: 29799001
[No Abstract] [Full Text] [Related]
36. [Univariate and multivariate regression analyses of recurrence and metastasis of colon cancer after radical resection].
Ren JQ; Zhou ZW; Wan DS; Lu ZH; Chen G; Wang GQ; Tang SX; Wang JJ
Ai Zheng; 2006 May; 25(5):591-5. PubMed ID: 16687080
[TBL] [Abstract][Full Text] [Related]
37. Prognostic impact of carcinoembryonic antigen and carbohydrate antigen 19-9 in stage IV colorectal cancer patients after R0 resection.
Abe S; Kawai K; Ishihara S; Nozawa H; Hata K; Kiyomatsu T; Tanaka T; Watanabe T
J Surg Res; 2016 Oct; 205(2):384-392. PubMed ID: 27664887
[TBL] [Abstract][Full Text] [Related]
38. Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): a randomised, double-blind, placebo-controlled, phase 2 trial.
Krop IE; Mayer IA; Ganju V; Dickler M; Johnston S; Morales S; Yardley DA; Melichar B; Forero-Torres A; Lee SC; de Boer R; Petrakova K; Vallentin S; Perez EA; Piccart M; Ellis M; Winer E; Gendreau S; Derynck M; Lackner M; Levy G; Qiu J; He J; Schmid P
Lancet Oncol; 2016 Jun; 17(6):811-821. PubMed ID: 27155741
[TBL] [Abstract][Full Text] [Related]
39. Lymphatic Permeation Predicts Systemic Recurrence in Combination with Vascular Involvement in Laparoscopically Resected N0 Colon Cancer.
Kojo K; Katoh H; Naito M; Yamashita K; Nakamura T; Sato T; Yamanashi T; Watanabe M
Am Surg; 2017 Dec; 83(12):1394-1400. PubMed ID: 29336761
[TBL] [Abstract][Full Text] [Related]
40. Bevacizumab plus chemotherapy versus chemotherapy alone as second-line treatment for patients with HER2-negative locally recurrent or metastatic breast cancer after first-line treatment with bevacizumab plus chemotherapy (TANIA): an open-label, randomised phase 3 trial.
von Minckwitz G; Puglisi F; Cortes J; Vrdoljak E; Marschner N; Zielinski C; Villanueva C; Romieu G; Lang I; Ciruelos E; De Laurentiis M; Veyret C; de Ducla S; Freudensprung U; Srock S; Gligorov J
Lancet Oncol; 2014 Oct; 15(11):1269-78. PubMed ID: 25273342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
